CVS Health reported quarterly EPS of $2.57, beating the Zacks Consensus Estimate of $2.21 by $0.36 per share, and up from $2.25 a year ago. The result is a positive earnings surprise that suggests better-than-expected operating performance, though the article provides no guidance or revenue details.
CVS Health reported quarterly EPS of $2.57, beating the Zacks Consensus Estimate of $2.21 by $0.36 per share, and up from $2.25 a year ago. The result is a positive earnings surprise that suggests better-than-expected operating performance, though the article provides no guidance or revenue details.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.28
Ticker Sentiment
